<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00583011</url>
  </required_header>
  <id_info>
    <org_study_id>AmniocentesisPain</org_study_id>
    <nct_id>NCT00583011</nct_id>
  </id_info>
  <brief_title>Local Anesthesia and Pain Perception During an Amniocentesis</brief_title>
  <official_title>Local Anesthesia and Pain Perception During Amniocentesis: A Randomized Placebo-controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Oklahoma</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Oklahoma</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is been designed to answer the question of whether local anesthesia (1% lidocaine)
      decreases the perception of pain associated with amniocentesis in a randomized double blind
      placebo controlled manner. Our objective is to determine the effect of local anesthesia on
      the maternal pain perception from an amniocentesis.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Women meeting criteria for project and agreeing to treatment will be randomized into either
      the 1% Lidocaine or placebo(normal saline) group. The initial injection of either 1%
      lidocaine or placebo (normal saline) will be administered 2 minutes prior to the
      amniocentesis procedure. 2cc of 1% lidocaine or placebo (normal saline) will be initially
      administered as an intradermal &quot;wheal&quot;, followed by a deeper infiltration of the 1% lidocaine
      or placebo (normal saline) to the depth of the peritoneum. All procedures will be performed
      by either the Maternal-Fetal medicine (MFM) or the reproductive geneticist utilizing
      continuous ultrasound guidance under sterile conditions. Each woman will be asked to rate
      their pain perception immediately after the procedure on two pain scales.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>October 2007</start_date>
  <completion_date type="Actual">May 2011</completion_date>
  <primary_completion_date type="Actual">May 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Intensity of perceived maternal pain as measured by a the two pain scales: 101 point Numerical Rating Scale (NRS-101) as well as the Visual Analogue Scale (VAS)</measure>
    <time_frame>2 years</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">70</enrollment>
  <condition>Pregnancy</condition>
  <arm_group>
    <arm_group_label>A</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Local anesthesia group</description>
  </arm_group>
  <arm_group>
    <arm_group_label>B</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Placebo normal saline group</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Local anesthesia - lidocaine</intervention_name>
    <description>Local anesthesia: 2 cc of 1% Lidocaine</description>
    <arm_group_label>A</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo Group</intervention_name>
    <description>Placebo Group: 2cc Normal Saline</description>
    <arm_group_label>B</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Singleton pregnancies

          -  Signed consent to participate in the trial

          -  Women between the ages of 18 and 45 years

          -  Gestational ages 15 - 24 weeks

        Exclusion Criteria:

          -  Multiple gestation

          -  Refusal to participate in the trial

          -  Known hypersensitivity to lidocaine

          -  Amniocentesis during this pregnancy

          -  Amnioinfusion/amnioreduction where the procedure is likely to be prolonged
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Andrew Elimian, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Oklahoma</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Oklahoma Health Sciences Center</name>
      <address>
        <city>Oklahoma City</city>
        <state>Oklahoma</state>
        <zip>73104</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 19, 2007</study_first_submitted>
  <study_first_submitted_qc>December 27, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 28, 2007</study_first_posted>
  <last_update_submitted>April 10, 2017</last_update_submitted>
  <last_update_submitted_qc>April 10, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">April 12, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Amniocentesis</keyword>
  <keyword>Genetic amniocentesis</keyword>
  <keyword>Fetal lung maturity</keyword>
  <keyword>Pain control</keyword>
  <keyword>Pregnancy</keyword>
  <keyword>High risk pregnancy</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anesthetics</mesh_term>
    <mesh_term>Lidocaine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

